Specific drugs for specific ventricular arrhythmias: an evaluation of current therapy and the role of propafenone.
Drug management of ventricular arrhythmias follows few scientific principles. Specific therapy for specific arrhythmias must be a goal for the future. Already a few important arrhythmia subtypes demanding specific therapy have been identified. As new drugs become available, they may offer particular effects against identifiable clinical arrhythmias.
Murtazam
A
A
Academic Cardiology, Freeman Hospital, Newcastle-upon-Tyne, U.K.
Campbell
R W
RW
D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D011405:Propafenone / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D011405:Propafenone